Filariasis Clinical Trial
Official title:
A Phase 1, Bioavailability Study to Investigate the Pharmacokinetics, Safety and Tolerability of an Oxfendazole Tablet Formulation in a Randomized, Double-Blind, Placebo-Controlled Design After Single and Multiple Oral Dosing in Healthy Adult Volunteers
The study evaluates the pharmacokinetics (PK), safety and tolerability of oxfendazole, after administration as a tablet formulation in healthy male and female participants.
This is a randomized, placebo-controlled, double blinded, single center phase I bioavailability study with two Single Dose cohorts and one Multiple Doses cohort in a total of 30 healthy male and female healthy volunteers (10 per cohort). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03014167 -
Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH)
|
Phase 3 | |
| Completed |
NCT03383523 -
Relative Bioavailability Study of Emodepside IR-tablets and Solution
|
Phase 1 | |
| Completed |
NCT03383614 -
Safety, Tolerability and PK of Multiple-ascending Doses of Emodepside
|
Phase 1 | |
| Completed |
NCT00471666 -
Medical Implications of Coinfection With Malaria and Filariasis Parasites
|
N/A | |
| Completed |
NCT01628497 -
Exhaled NO Testing in Filariasis
|
N/A | |
| Recruiting |
NCT00001230 -
Host Response to Infection and Treatment in Filarial Diseases
|
||
| Completed |
NCT02927496 -
A 24 Month Study, to Compare the Efficacy of Doxycycline vs. Placebo for Improving Filarial Lymphedema in Mali
|
Phase 3 | |
| Completed |
NCT02929121 -
A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in India
|
Phase 3 | |
| Completed |
NCT01547884 -
Effect of Filarial Infection on Immune Responses in Latent Tuberculosis
|
||
| Completed |
NCT02929134 -
A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in Sri Lanka
|
Phase 3 |